These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6538514)

  • 21. Porcine tissue plasminogen activator. Immunoaffinity purification, structural properties and glycosylation pattern.
    Pohl G; Jörnvall H; Kok P; Wallén P
    FEBS Lett; 1986 Sep; 205(1):92-6. PubMed ID: 3091400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.
    Collen D; Rijken DC; Van Damme J; Billiau A
    Thromb Haemost; 1982 Dec; 48(3):294-6. PubMed ID: 6891842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
    De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
    J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
    J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enhancing effect of poly-lysine on the activation of plasminogen.
    Allen RA
    Thromb Haemost; 1982 Feb; 47(1):41-5. PubMed ID: 7200268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and properties of plasminogen activators from epithelial cells.
    Electricwala A; Atkinson T
    Eur J Biochem; 1985 Mar; 147(3):511-6. PubMed ID: 3920046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
    Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M
    Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Messenger RNA for human tissue plasminogen activator.
    Opdenakker G; Weening H; Collen D; Billiau A; de Somer P
    Eur J Biochem; 1982 Jan; 121(2):269-74. PubMed ID: 7199459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ; Kitson JL; Silvers WK; Mintz B
    Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.
    Bányai L; Váradi A; Patthy L
    FEBS Lett; 1983 Oct; 163(1):37-41. PubMed ID: 6685059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates.
    Astedt B; Bladh B; Christensen U; Lecander I
    Scand J Clin Lab Invest; 1985 Sep; 45(5):429-35. PubMed ID: 2930896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of two variants of native one-chain tissue plasminogen activator.
    Rånby M; Bergsdorf N; Pohl G; Wallén P
    FEBS Lett; 1982 Sep; 146(2):289-92. PubMed ID: 6890472
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.
    Larsson A; Astedt B
    J Clin Pathol; 1985 Feb; 38(2):140-5. PubMed ID: 3881480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a family of high-molecular-weight plasminogen activators secreted by a lung tumor cell line.
    Harvey SR; Loftus JR; Hurley EL; Ross ME; Markus G
    Biochim Biophys Acta; 1991 Jul; 1078(3):360-8. PubMed ID: 1859826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
    Holmberg L; Kristoffersson AC; Lecander I; Wallén P; Astedt B
    Scand J Clin Lab Invest; 1982 Jun; 42(4):347-54. PubMed ID: 6753100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of the amino- and carboxyl-termini of streptokinase.
    Fay WP; Bokka LV
    Thromb Haemost; 1998 May; 79(5):985-91. PubMed ID: 9609234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A; Nolli ML; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular species of plasminogen activators secreted by normal and neoplastic human cells.
    Wilson EL; Becker ML; Hoal EG; Dowdle EB
    Cancer Res; 1980 Mar; 40(3):933-8. PubMed ID: 7193517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.